Navigation Links
Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
Date:9/30/2009

. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause Raptor's actual results to be materially different from these forward-looking statements. Raptor cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date they were made. Certain of these risks, uncertainties, and other factors are described in greater detail in Raptor's filings from time to time with the Securities and Exchange Commission (the "SEC"), which Raptor strongly urges you to read and consider, including the joint proxy statement/prospectus on Form S-4 filed by TorreyPines on August 19, 2009; Raptor's Registration Statement on Form S-1, as amended, that was declared effective on August 7, 2008; Raptor's annual report on Form 10-K filed with the SEC on October 30, 2008, as amended by that Form 10-K/A filed with the SEC on December 23, 2008; and Raptor's Form 10-Q filed with the SEC on July 15, 2009, TorreyPines' annual report on Form 10-K filed with the SEC on March 27, 2009; and TorreyPines' quarterly report on Form 10-Q filed with the SEC on August 11, 2009, all of which are available free of charge on the SEC's web site at http://www.sec.gov. Subsequent written and oral forward-looking statements attributable to Raptor or to persons acting on its behalf are expressly qualified in their entirety by the cautionary statements set forth in Raptor's reports filed with the SEC. Raptor expressly disclaims any intent or obligation to update any forward-looking statements.

    For more information, please contact:
    Kim Tsuchimoto, CFO
    415-382-1390
    ktsuchimoto@raptorpharma.com

    The Ruth Group
    Sara Ephraim Pellegrino (investors) / Janine McCargo (media)
    (646) 536-7002 /
'/>"/>
SOURCE Raptor Pharmaceuticals Corp.; TorreyPines Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
2. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
3. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
4. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
5. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
6. Raptor Pharmaceuticals Provides Update on Targeting Platforms
7. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
8. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
9. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
10. Raptor Pharmaceuticals Provides Update of Product Programs
11. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... MILWAUKEE , Sept. 4, 2015  Dohmen Company ... speaker for the Metropolitan Milwaukee Association of Commerce,s annual ... 10 at the Pfister Hotel. The ,Future 50, Awards ... established businesses and young firms headquartered in the seven-county ... Dohmen has called Milwaukee home ...
(Date:9/4/2015)... Sept. 4, 2015  Luminex Corporation (NASDAQ: LMNX ... Morgan Stanley Global Healthcare Conference to be held September ... in New York City . ... Eastern time on Friday, September 18, 2015.  The presentation ... Corporation,s website at http://www.luminexcorp.com . Simply log on to ...
(Date:9/4/2015)... September 4, 2015 According to ... (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) by Procedure (Therapeutic ... Product - Global Forecast to 2020", published by MarketsandMarkets, ... 2.5 Billion by 2020, growing at a CAGR of ... Browse 139 Tables and 45 F ...
Breaking Medicine Technology:Dohmen CEO Cynthia LaConte to Keynote MMAC 'Future 50' Awards Luncheon 2Luminex Corporation To Present At The Morgan Stanley Global Healthcare Conference 2Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5
... Wis., May 15 Omega 3 fatty acids ... a credible natural,alternative and may have beneficial effect ... study reveals. While several studies have reported,beneficial effects ... Vectomega(R) could have specific positive effects on,impulse control., ...
... NEW YORK and WASHINGTON, May 14 Revolution ... up to offer patients and,physicians the largest personalized ... United States. Individuals can quickly assess their,eligibility for ... confidential,and efficient way through an online search engine ...
Cached Medicine Technology:Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 2Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 3Revolution Health and EmergingMed Launch Cancer Clinical Trial Matching and Referral Service 2
(Date:9/4/2015)... , ... September 04, 2015 , ... Lalonde Gordon ran ... and followed up with victory in the men’s 400 meters final, with an impressive ... and Field Championships in San Jose, Costa Rica in August 2015. The 44.64 time ...
(Date:9/4/2015)... ... September 04, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... involving the Pope’s upcoming trip to the United States. , Yisrayl lays out what he ... the Vatican and society is. Yisrayl also provides the meaning of his own name and ...
(Date:9/4/2015)... ... ... Friday night, Chicago lovebirds Jenny McCarthy and Donnie Wahlberg celebrated their one-year ... families affected by autism, raising nearly $250,000. , 150 guests, including event co-chairs ... Swan Inn to support the cause. , McCarthy tugged the heartstrings of everyone ...
(Date:9/3/2015)... ... September 03, 2015 , ... Allied Anesthesia is proud to ... is the norm not the exception. , St. Jude was recently named one of ... Stroke Association, making it one of only 10 hospitals in the state to earn ...
(Date:9/3/2015)... New York (PRWEB) , ... September 03, 2015 , ... ... Do”. William Mattar, Esq. believes this does not stop at any certain demographic ... captioning to its newly produced one-minute, thirty-, fifteen- and ten-second TV commercials. , The ...
Breaking Medicine News(10 mins):Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2
... ophthalmologist at UT Southwestern Medical Center has helped create a ... disease better track vision changes. With the hand-held digital ... in less than 90 seconds, said Dr. Yu-Guang He, associate ... do not have timely eye exams and end up suffering ...
... [EMBARGOED FOR JULY 26, 2011] Antibiotic overuse and resistance ... decades. Following an outbreak of Clostridium difficile infections, which ... Quebec, Canada targeted physicians and pharmacists with an education ... study published in Clinical Infectious Diseases and ...
... July 25 (HealthDay News) -- Parents of children with attention-deficit/hyperactivity disorder ... than 10 years old with ADHD may be unable to cross ... that while children with ADHD may look as if they are ... look both ways before crossing -- they aren,t always good at ...
... gravel roads in Dunn County, North Dakota, they stir up ... wake contain such high levels of the mineral erionite that ... an increased risk of developing mesothelioma, a type of cancer ... is a natural mineral fiber that shares similar physical similarities ...
... July 25 (HealthDay News) -- Although many Americans continue ... likely to remain on the job after they turn ... The researchers also found that lower-income workers are ... particularly arthritis, later in life. As a result, the ...
... MONDAY, July 25 (HealthDay News) -- People who resume smoking ... die than those who quit for good, a new Italian ... relapsed were three to five times more likely to die ... need to do more to support long-term ,smoking-cessation efforts after ...
Cached Medicine News:Health News:UT Southwestern ophthalmologist helps develop device for monitoring degenerative eye disease 2Health News:Simple guidelines decreased unnecessary antibiotic use in Quebec, Canada 2Health News:Kids With ADHD Less Adept at Crossing the Street: Study 2Health News:Kids With ADHD Less Adept at Crossing the Street: Study 3Health News:New study finds cancer-causing mineral in US road gravel 2Health News:New study finds cancer-causing mineral in US road gravel 3Health News:Blue-Collar Employees With Arthritis Working Past 65: Study 2Health News:Smoking After Heart Attack Raises Risk of Dying 2
... VERSASTEP™ Plus Short Instrument ... , ,The VERSASTEP™ Plus ... Working Length is a unique ... applications in laparoscopic procedures. It ...
... Trocar consists of a blunt obturator connected ... assembly. , ,The valve body assembly ... to prevent gas leakage when instruments are ... Trocar includes built-in converters to allow insertion ...
... Premium One-Step™ single-use system device is comprised ... device components for creating each access port ... , Step™ insufflation and access needle, ... separately. , Step™ radially expandable sleeve, 100 ...
... contains an internal seal to prevent gas leakage ... of pneumoperitoneum. The 5 mm PLUS system includes ... mm - 12 mm as appropriate and is ... of the trocar to allow insertion of smaller ...
Medicine Products: